Dexcom has grown revenue 16% a year over three years and 18% a year over five, with earnings per share compounding at 43%. Revenue growth, 3-year annual rate: +16% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +18%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +43%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

DXCMDexcom

HealthcareUSD

$88.96

$54.8452 weeks$92.35

Is it growing?

Is DXCM growing?

Dexcom has grown revenue 16% a year over three years and 18% a year over five, with earnings per share compounding at 43%.

+16%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +16% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +43%
Earnings per share, 3-year rate · revenue +16% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed